Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Actinogen Says No Unannounced Information Behind Trading, Points to Mid-November Trial Results

ACW: $0.048 +17.07% · MC: $182M

Actinogen Medical told the ASX it knows of no unannounced information that could explain recent trading in its shares. It pointed to its October update that the XanaMIA Alzheimer’s trial had reached database lock, with topline results expected in mid-November 2026.

Source announcements: 2026-11-09 16:31 to 2026-11-09 16:31 Sydney time
Story updated 2026-11-09 16:37 Sydney time
SourcesResponse to ASX Price Query
Comments